Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Noble (NE) benefits from improving dayrates and a $7B-ish backlog, but trailing EPS, fleet mix, and reactivation costs keep margins constrained. EV/EBITDA sits at ~8.5x while P/E is near 45x, a mismatch that creates a tactical short opportunity. Trade plan: short at $42.00, target $36.00, stop $46.00 — mid-term (45 trading days), high risk.
StoneCo (STNE) looks positioned for a mid-term rally into and following Brazil's October 25, 2026 presidential runoff. The stock trades at a steep discount to fundamentals (market cap ~$2.82B, P/E ~4.5) and shows bullish technicals and concentrated short activity — a classic catalyst-driven trade. I lay out a precise entry, stop and target with a 4…
Thursday’s Houthi missile strikes on Riyadh airport killed three people and wounded others, Saudi authorities said, while regional airstrikes and a widening ground offensive in Yemen have heightened risks to aviation, maritime transit and global oil markets. Flights were disrupted as airlines suspended services to the Saudi capital ahead of a major…
Home Depot (HD) is trading well below its 52-week high, paying a >3% yield and generating strong free cash flow. The stock is sensitive to mortgage rates: a meaningful pullback in rates or evidence of improving housing activity should re-rate the shares. This is a mid-term swing trade that keeps risk defined while leaning on the company’s cash gene…
NPK International (NPKI) has pulled back from spring highs and is trading near the low end of its 52-week range. The company operates in construction and power-infrastructure end markets that feed datacenter builds and other critical projects. Low leverage, positive free cash flow, and a modest valuation versus growth justify a tactical long. Trade…
OceanaGold (OGC) trades at roughly $5.95B market cap ($26.67/sh) with a low P/E (6.9) and a modest dividend yield. The company runs a clean balance sheet, operates four producing assets across the U.S., New Zealand and the Philippines, and still has upside from development at Haile. Technical indicators are soft, which creates a reasonable entry fo…
UBS warns that gold could be pushed back toward $4,000 an ounce in the near term as higher U.S. real yields and a stronger dollar increase the opportunity cost of holding the metal. The bank expects that structural dip buyers will establish a floor around that level, while forecasting a gradual rise in prices through 2027 supported by central bank …
Corteva trades at a materially depressed valuation with a roughly $9.16B market cap, >$600M in free cash flow and a near-5% dividend yield. Recent corporate actions (spinoff), margin gains in crop protection, and accommodative balance sheet metrics argue for a long trade around current levels. This is a tactical long: entry $13.50, target $19.00, s…
VEON Ltd. announced that its Bangladeshi operator Banglalink has launched a satellite-to-mobile service powered by Starlink, making Bangladesh the first South Asian country to offer this technology. This initiative enhances connectivity beyond traditional mobile networks, especially during emergencies and disasters. The move supports VEON's broader…
PayPal trades at a valuation that assumes persistent checkout weakness. We think the market underestimates alternative growth levers - Venmo monetization, merchant tools, and sustained free cash flow - that can re-rate the stock. This is a mid-term swing trade: enter around $55.00, stop at $49.00, target $72.00 over the next 45 trading days.
Alumis Inc. announced new Phase 3 ONWARD clinical program data demonstrating that envudeucitinib rapidly and durably improves psoriasis symptoms including scalp clearance, itch relief, and quality of life. The drug showed a 54% complete skin clearance (PASI 100) response at Week 48, the highest among oral therapies. The medication was well tolerate…
CMB.TECH NV has launched Mineral Europa, the first ammonia-powered dry bulk vessel, marking a breakthrough in green maritime propulsion that could revolutionize the shipping industry by eliminating CO2 emissions. This vessel is the first of 21 ammonia-powered ships scheduled to join the company's fleet by 2029, supporting decarbonization and energy…
Orange shares fell 2.5% to €13.88 in today's session as investor concerns about heightened competition, a pessimistic analyst downgrade and an adverse macro backdrop for French assets intensified selling pressure. Morgan Stanley's Underweight call and €15 price target, worries about slowing EBITDAaL growth in France through 2027, and broader market…
Danantara, Indonesia’s state investment vehicle, says it could buy into local equities during periods of market stress if valuations are attractive, is cautiously adding AI exposure, and may retain a planned dividend rather than immediately remit it to the government. Executives outlined the fund’s asset allocation, recent and planned public-market…
Alphabet is uniquely positioned to monetize the next wave of AI through owned compute (TPUs), Google Cloud distribution, Gemini models in search/ads, and large custom compute deals. At $345.29 and a $4.24T market cap, valuations look reasonable vs. growth and cash generation. This trade targets continued AI-driven revenue upside and margin expansio…
The Financial Stability Board (FSB) has identified significant shortcomings in many jurisdictions' ability to provide rapid emergency funding to banks under acute liquidity stress. In a peer review of progress against its resolution standards, the FSB found fewer than half of countries had funding mechanisms that were clearly defined, sufficiently …
Bladex (BLX) blends a high-single-digit yield with cheap valuation (PE ~9, PB ~1.3) and improving technicals. We like a tactical long into a potential re-rating as the company leans into capital-light Treasury returns and preserves a healthy dividend. Trade plan: enter $54.80, stop $50.00, target $63.00 over a mid-term 45 trading day horizon.
A surge in tanker freight rates to record levels has made shipping US crude to Asia uneconomical, prompting refiners to pivot toward Middle Eastern and Latin American grades. Traders and shipbrokers tracking the market say the cost to charter very large crude carriers (VLCCs) has vaulted to tens of millions of dollars per voyage, closing the arbitr…
Quantisimo Corp., a sovereign quantum technology platform formed by WISeQey and SEALSQ, has signed a definitive business combination agreement with GigCapital8 Corp., a Nasdaq-listed SPAC, to go public under the ticker QSMO. The transaction values Quantisimo at approximately $666.1 million and aims to integrate quantum computing, networking, cybers…
Invesco (IVZ) is trading near $30 with a market cap around $13.3B, free cash flow of roughly $1.92B and AUM momentum that continues to surprise to the upside. The market has punished the stock for episodic earnings volatility, leaving valuation stretched on the downside. This trade targets a mid-term rebound as flows and cash generation re-rate the…
Nano Labs is a tiny fabless chip and AI-hardware play that combines an early-stage product pipeline with a meaningful crypto reserve. The stock trades at a sub-$50M market cap, recent operating results are weak, but catalysts over the next 1-6 months could push the business toward a positive cash flow inflection if hardware sales and blockchain ini…
Retension Pharmaceuticals, a clinical-stage biopharmaceutical company focused on cardiovascular diseases, has priced its upsized IPO at $12 per share, aiming to raise $45 million. The funds will support completion of the Phase 2b trial and preparation for Phase 3 trials of RTN-001, a novel treatment for uncontrolled hypertension. Shares are set to …
TRex Bio, a clinical-stage biotech company specializing in tissue regulatory T cell biology for developing immunoregulatory therapies, announced the pricing of its IPO at $14.00 per share, offering 8,333,334 shares on Nasdaq under ticker TRXB. The gross proceeds of approximately $116.7 million will support further drug discovery and development eff…
Clover Health announced that its Medicare Advantage PPO plans received a prestigious 5 Star rating from the Centers for Medicare & Medicaid Services for 2027, which enhances payment rates and allows year-round enrollment. The company experienced a 48% year-over-year membership growth in Medicare Advantage through mid-2026, driven primarily by its P…
Pharvaris announced publication of Phase 3 RAPIDe-3 study results in The Lancet showing that oral deucrictibant immediate-release capsules provide rapid onset and sustained relief of hereditary angioedema (HAE) attacks with a well-tolerated safety profile. The study met all primary and secondary endpoints, supporting regulatory reviews in the U.S. …
